Patent · US Active

Ultra-pure agonists of guanylate cyclase C, method of making and using same

US11319346B2 · kind B2 · utility

2Cited by

19References

12Claims

0Family size

Assignee

Bausch Health Ireland Limited · IE

Inventors

Kunwar Shailubhai · Audubon, US
Stephen Comiskey · Doylestown, US
Rong Feng · Langhorne, US
Juncai Bai · North Augusta, US
Ruoping Zhang · Penn Hills, US
Jun Jia · Beijing, CN
Junfeng Zhou · Redmond, US
Qiao Zhao · Shanghai, CN
Guoqing Zhang · Beijing, CN

Key dates

Filing date	Sep 17, 2021
Grant date	May 3, 2022
Priority date	—
Expiry date	Sep 17, 2041

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Y406/01002
WIPO fieldChemical engineering
WIPO sectorChemistry

Abstract

The invention provides processes of purifying a peptide including a GCC agonist sequence selected from the group consisting of SEQ ID NOs: 1-251 described herein. The processes include a solvent exchange step before a freeze-drying (lyophilization) step.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.